Panel on gene patenting, the Supreme Court's Myriad decision, and the future of biotechnology - Смотреть видео или скачать видео в MP4, музыку MP3 на телефон или компьютер
Experts in the fields of law, science, and technology gathered at Harvard Law School Sept. 23 for a panel discussion, co-sponsored by the Broad Institute of MIT and Harvard, examining the impact of the U.S. Supreme Court's recent decision that naturally occurring DNA cannot be patented.